These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20047927)

  • 1. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.
    Maines M; Catanzariti D; Cirrincione C; Valsecchi S; Comisso J; Vergara G
    Europace; 2010 May; 12(5):680-5. PubMed ID: 20047927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathoracic impedance and ultrasound lung comets in heart failure deterioration monitoring.
    Maines M; Catanzariti D; Angheben C; Valsecchi S; Comisso J; Vergara G
    Pacing Clin Electrophysiol; 2011 Aug; 34(8):968-74. PubMed ID: 21477028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT; Compton S; Haas G; Foreman B; Canby RC; Fishel R; McRae S; Toledo GB; Sarkar S; Hettrick DA;
    Congest Heart Fail; 2011; 17(2):51-5. PubMed ID: 21449992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
    Catanzariti D; Lunati M; Landolina M; Zanotto G; Lonardi G; Iacopino S; Oliva F; Perego GB; Varbaro A; Denaro A; Valsecchi S; Vergara G;
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):363-70. PubMed ID: 19272067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Zile MR; Colombo PC; Mehra M; Greenberg B; Brown S; Konstam MA
    J Heart Lung Transplant; 2010 Jan; 29(1):86-92. PubMed ID: 20123246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
    Packer M; Abraham WT; Mehra MR; Yancy CW; Lawless CE; Mitchell JE; Smart FW; Bijou R; O'Connor CM; Massie BM; Pina IL; Greenberg BH; Young JB; Fishbein DP; Hauptman PJ; Bourge RC; Strobeck JE; Murali S; Schocken D; Teerlink JR; Levy WC; Trupp RJ; Silver MA;
    J Am Coll Cardiol; 2006 Jun; 47(11):2245-52. PubMed ID: 16750691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of elevated pulmonary capillary wedge pressure in elderly patients with various cardiac disorders by the Valsalva manoeuvre.
    Remmen JJ; Aengevaeren WR; Verheugt FW; Jansen RW
    Clin Sci (Lond); 2006 Aug; 111(2):153-62. PubMed ID: 16545074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiopathologic correlates of intrathoracic impedance in chronic heart failure patients.
    Tomasi L; Zanotto G; Zanolla L; Golia G; Ometto R; Bonanno C; Vergara G; Maines M; Lonardi G; Visentin E; Rauhe W; Latina L; Perrone C; Varbaro A; DE Santo T;
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):407-13. PubMed ID: 21091745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
    Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT.
    Maines M; Landolina M; Lunati M; Lonardi G; Pappone A; Proclemer A; Zanotto G; Santini M; Varbaro A; Vimercati M; Valsecchi S;
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):64-73. PubMed ID: 19821939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.